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few studies, some nanoparticles have been suggested to change
the expression of some apoptotic genes. In our study, we evaluated
the epigenetic changes in some apoptosis-related genes in human
cervical carcinoma (HeLa) cell lines treated with a wide concentra-
tion range of (10, 40,125, 500 g/ml) of 2-mercaptopropionic acid
(2-MPA)-coated silver sulfide QD by real-time polymerase chain
reaction (RT-PCR) assay. The RT-PCR results showed that 2-MPA QD
at the concentrations 10–500 M affected the apoptotic genes (bax,
bcl2 and caspase-9) in HeLa cells. However, more genes related to
apoptosis should further be examined to understand the possible
apoptotic mechanisms of QDs.
http://dx.doi.org/10.1016/j.toxlet.2016.06.1964
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Ceria nanoparticles (CeO2 NPs) have several industrial appli-
cations and pharmacological potential due to their antioxidant
properties. However, toxicity data on CeO2 NPs are scarce and show
contradictory results. In the present study, uncoated, polyethylene
glycol- and citrate-coated CeO2 NPs (4-8 nm) were administrated
to C57Bl/6 mice by repeated dose (3×) pharyngeal aspiration using
four different doses of each type of NPs (corresponding to 4.4, 8.8,
17.6 and 35.2 g Ce2+/mouse/aspiration), and sampled 1 and 28
days after the last administration. DNA damage was assessed by the
comet assay locally in bronchoalveolar lavage (BAL) and lung cells,
and systemically in liver cells. Micronuclei, a biomarker of chromo-
some damage, were analysed in bone marrow and peripheral blood
erythrocytes. Immunotoxicity was evaluated by BAL cell counting.
Furthermore, histopathological effects on the lungs and biodistri-
bution of the NPs (analysis of Ce2+ in several organs) were assessed.
At 24-h, a significant increase in DNA damage was induced at the
highest doses by uncoated and citrate-coated NPs in BAL cells.
For these NPs a significant, but non-dose-dependent, effect was
observed in lung and liver cells at 28-d. No systemic genotoxic
effects were observed with any of the NPs. A dose-dependent accu-
mulation of macrophages and activated lymphocytes was seen in
the lungs for all the NPs, although a milder reaction was elicited
by the coated NPs. Our findings show that short-term exposure of
mice to CeO2 NPs induces pulmonary inflammation, and non-dose-
dependent DNA damage, but no systemic genotoxicity. (Funded by
the EU FP-7 GUIDEnano, Grant Agreement No.604387).
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Iron oxide nanoparticles (Fe2O3-NPs) have been widely used
for various biomedical applications such as drug delivery, mag-
netic resonance imaging contrast enhancement, and in the targeted
destruction of tumor tissue through hyperthermia. Increasing
applications raise concerns over their potential effects on human
health so their effects, including genotoxic effects, need to be thor-
oughly understood. The present study was planned to determine
the genotoxic effect of Fe2O3 NPs in cultured human lymphocytes
using the chromosomal aberration (CA) assay. Lymphocytes were
treated with different concentrations (39.062, 78.125, 156.250,
312.500 g/mL) of Fe2O3 NPs (Sigma–Aldrich, <100 nm) for 24 h
and 48 h. The results show that NPs increased the frequency of
CAs at both 24 h and 48 h. This increase was significant at 156.250
and 312.500 g/mL at 24 h (r = 0.88) and at only 312.500 g/mL at
48 h treatment (r = 0.94). On the other hand, Fe2O3 NPs decreased
the mitotic index, this decrease was significant at the highest
concentration (312.500 g/mL) at 24 h and at the two highest con-
centrations (156.250 g/mL, 312.500 g/mL) at 48 h. The results
observed in this study indicated that Fe2O3 NPs may have clas-
togenic and cytotoxic effects at high concentrations. While NPs
toxicity can be considered useful for cancer therapy, simultane-
ously it seems harmful for non-cancer cells. Recent studies show
that NPs can cause epigenetic and genomic changes which may
stimulate cancer progression. So, attention should be paid for the
use of nanoparticles and some more study on the genotoxicity of
Fe2O3 NPs is necessary.
http://dx.doi.org/10.1016/j.toxlet.2016.06.1966
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Betulinic acid is a compound of natural origin, member
of the pentacyclic triterpenes family, known to exert multiple
pharmacological properties, like: antitumoral, anti-inflammatory,
antiangiogenic, immunomodulatory, hepatoprotective and other
effects. It was also proved that even at high doses administered
in vivo (500 mg/kg body weight), no toxicity was observed. A major
handicap of this compound is represented by its very low water sol-
ubility what leads to a diminished administration in vivo. The aims
of the present study were to obtain a silver nanoparticle solution of
betulinic acid soluble in aqueous solution and to assess the effects
of this new formulation in vitro on a panel of tumor cell lines.
The experiments were conducted on human melanoma – A375,
murine melanoma – B164A5, lung (A549) and liver carcinoma
(HepG2) and breast cancer carcinoma – MCF-7 cell lines. The cells
